Influence of hemodialysis on total and free malondialdehyde measured by a new HPLC method;Influence de l'hémodialyse sur les concentrations de malonedialdéhyde total et libre, mesurées par une nouvelle technique HPLC spécifique

Nephrologie et Therapeutique

Volumn 1, Issue 2, 2005, Pages 121-125

  Steghens, Jean Paul ^a   Combarnous, François ^a   Arkouche, Walid ^b   Flourie, Françoise ^a   Hadj Aissa, Aoumeur ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b Association AURAL   (France)

Author keywords

Haemodialysis; Lipoperoxidation; Malondialdehyde; Oxidative stress

Indexed keywords

MALONALDEHYDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DRUG BINDING; DRUG BLOOD LEVEL; FEMALE; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID PEROXIDATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; SENSITIVITY AND SPECIFICITY;

EID: 23244450765     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nephro.2004.04.001     Document Type: Article

References (21)

1. Tetta C, Biasoli S, Schiavon R, et al. An overview of haemodialysis and oxidant stress. In: Lameire N, Tetta C, Ronco C, editors. Haemodialysis and Oxidant Stress. Basel, Karger; 1999. p. 118-26.
2. Descamps-Latscha B. Witko-Sarsat. Le stress oxydant dans l'insuffisance rénale chronique et l'hémodialyse. Nephrol 2003;24:377-9.
3. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998;9(Suppl. 12):16S-23S.
4. Drueke TB, Khoa TN, Massy ZA, et al. Role of oxidized low-density lipoprotein in the atherosclerosis of uremia. Kidney Int 2001;59(Suppl. 78):114S-119S.
5. Morena M, Martin-Mateo M, Cristol JP, Canaud B. Stress oxydant, hémo-incompatibilité et complications de la dialyse au long cours. Nephrol 2002;23:201-8.
6. Hartley DP, Kolaja KJ, Reichard J, et al. 4 Hydroxynonenal and Malonedialdehyde Hepatic Protein Adduct in Rats Treated with Carbon Tetrachloride. Immunochemical Detection and Lobular Localization. Toxicol Appl Pharmacol 1999;161:23-33.
7. Kearley ML, Patel A, Chien J, et al. Observation of a New Nonfluorescent Malonedialdehyde-Acetaldehyde-Protein Adduct by 13C NMR Spectroscopy. Chem Res Toxicol 1999; 12:100-5.
8. Benzie IFF. Lipid peroxidation: a review of causes, consequences, measurement and dietary influences. Int J Food Sci Nutr 1996;47:233-61.
9. Boaz M, Matas Z, Biro A, et al. Comparison of Hemostatic Factors and Serum Malonedialdehyde as Predictive Factors for Cardiovascular Disease in Haemodialysis Patients. Am J Kidney Dis 1999;34:438-434.
10. Daschner M, Lenhartz H, Botticher D, et al. Influence of dialysis on plasma lipid peroxidation products and antioxidant levels. Kidney Int 1996;50:1268-1262.
11. Peuchant E, Carbonneau MA, Dubourg L, et al. Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: vitamins A, E, and iron status. Free Rad Biol Med 1994;16:339-336.
12. Satoh M, Yamasiki Y, Kasahara J, et al. Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters. Kidney Int 2001;59:1943-50.
13. Galli F, Varga Z, Balla J, et al. Vitamin E, lipid profile, and peroxidation in haemodialysis patients. Kidney Int 2001; 59(Suppl. 78):148S-141S.
14. Steghens JP, van Kappel A, Denis I, et al. Diaminonaphtalene, a new highly specific reagent for HPLC-UV measurement of true total and free malonedialdehyde in human plasma or serum. Free Rad Biol Med 2001;31:242-9.
15. Libetta C, Zucchi M, Gori E, Sepe V, Galli F, Meloni F, et al. Vitamin E-loaded dialyser resets PBMC-operated cytokine network in dialysis patients. Kidney Int 2004;65:1473-81.
16. Mann JFE, Lonn EM, Yi Q, Gerstein HC, Hoogwerf BJ, Pogue J, et al. Effects of vitamin E on cardiovascular outcoms in people with-to-moderate renal insufficiency : Results of the HOPE study. Kidney Int 2004;65:1375-80.
17. Lepage G, Munoz G, Champagne J, et al. Preparative Steps Necessary for the Accurate Measurement of Malonedialdehyde by HPLC. Anal Biochem 1991;197:277-271.
18. Zima T, Haragsim L, Stipek S, et al. Lipid peroxidation on dialysis membranes. Biochem Mol Biol Int 1993;29:531-7.
19. Weinstein T, Chagnac A, Korzets A, et al. Haemolysis in haemodialysis patients: evidence for impaired defence mechanisms against oxidative stress. Nephrol Dial Transplant 2000;15:883-7.
20. Romero FJ, Bosch-Morell F, Romero MJ, et al. Lipid Peroxidation Products and Antioxidants in Human Disease. Environ Health Perspect 1998;106(Suppl 5):1229S-1224S.
21. Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, et al., European Uremic Toxin Work Group (EUTox). Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63(5):1934-43 (Review).